Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

ARCTARCT
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in ARCTURUS THERAPEUTICS HLDGS

GOLDMAN SACHS GROUP INC holds 309,863 shares of ARCT (ARCTURUS THERAPEUTICS HLDGS), worth $2.1M as of 2026-Q2. The position was increased (+56.0% shares). ARCT represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$2.1M

Current Shares

309,863

Total Value Change

-$5.8M

Total Shares Change

-157,213

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
309,863
+56.0%
$2.1M0.0%$6.72
37
2026-Q1
Decreased
198,681
-49.2%
$1.5M0.0%$7.91
0
2025-Q4
Increased
391,227
+170.3%
$2.4M0.0%$6.19
42
2025-Q3
Decreased
144,728
-76.7%
$2.7M0.0%$18.78
0
2025-Q2
Increased
620,257
+21.7%
$8.1M0.0%$13.33
33
2025-Q1
Increased
509,712
+9.1%
$5.4M0.0%$11.58
30
2024-Q4
New
467,076
-
$7.9M0.0%$16.58
38

Other major holders of ARCT: BNP PARIBAS FINANCIAL MARKETS, ARK Investment Management LLC, FEDERATED HERMES, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used